Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Invictus MD Strategies Corp IVITF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

Recent & Breaking News (GREY:IVITF)

INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT

GlobeNewswire October 23, 2019

INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.

GlobeNewswire October 17, 2019

INVICTUS ANNOUNCES APPOINTMENT OF INTERIM CEO AND ALTERNATE DIRECTOR

GlobeNewswire October 8, 2019

INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

GlobeNewswire September 24, 2019

INVICTUS ENTERS INTO AGREEMENT TO SELL FUTURE HARVEST DEVELOPMENT LTD.

GlobeNewswire September 20, 2019

INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE

GlobeNewswire September 11, 2019

INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS

GlobeNewswire August 30, 2019

ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL

GlobeNewswire August 27, 2019

Invictus MD Strategies Corp. Opens the Market

Canada NewsWire August 19, 2019

ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

GlobeNewswire August 14, 2019

GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS

GlobeNewswire August 12, 2019

ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY

GlobeNewswire August 6, 2019

Invictus announces Annual General Meeting Results

GlobeNewswire July 25, 2019

Invictus announces Closing of Non-Brokered Private Placement

GlobeNewswire July 9, 2019

Invictus announces Non-Brokered Private Placement

GlobeNewswire July 3, 2019

INVICTUS ANNOUNCES AB VENTURES INC. UPDATE

GlobeNewswire July 2, 2019

INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS

GlobeNewswire June 28, 2019

INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

GlobeNewswire June 26, 2019

Invictus announces Annual General Meeting Date

GlobeNewswire June 20, 2019

UPDATE ON ACREAGE PHARMS LTD.

GlobeNewswire June 12, 2019